Hinge Health (HNGE) closed at $115.48 on Nov 2, 2026, up 1.0% on the day. The stock is up 18.2% over the past month, up 45.4% over three months, up 148.6% year to date and up 132.1% over the past year (since Oct 31, 2025). It trades 2.8% below its 52-week high of $118.86 and 283.9% above its 52-week low of $30.08. The close sits above its 50-day moving average ($98.71) and above its 200-day moving average ($67.42).
HNGE options were pricing 71% at-the-money implied volatility on Oct 29, 2026, an IV rank of 45 over the past year.
Yes — the Nov 2, 2026 close of $115.48 is 71.3% above the 200-day average of $67.42.
HNGE closed 2.8% below its 52-week high of $118.86.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
